Bicycle Therapeutics plc — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0c3697e3-d5de-474e-a2e9-42e655798ed5/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-219.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-028971 |
| FY 2024 | $-169.0M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-001438 |
| FY 2023 | $-180.7M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-001324 |
| FY 2022 | $-112.7M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002238 |
| FY 2021 | $-66.8M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002457 |
| FY 2020 | $-51.0M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002758 |
| FY 2019 | $-30.6M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002278 |
| FY 2018 | $-21.8M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002278 |
| FY 2017 | $-16.3M | 2017-01-01 – 2017-12-31 | evidence 0001558370-20-002278 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Bicycle Therapeutics plc — all facts · Revenue · Operating Income